Co-administration of an NOS inhibitor, L-NAME, promoted endothelial cell death, reduced capillarization, and suppressed cardiac function in EMPA-treated TAC mice (Fig. 5A–C), suggesting a causative role of the eNOS/NO pathway in mediating the cardioprotective effects of EMPA. Here, NOS1 is linked to persistent truncus arteriosus.